Erythropoiesis-stimulating agent injections employed in medical centers for managing anemia associated with chronic kidney disease and chemotherapy. Acquired by hospitals and oncology units from biotech manufacturers for subcutaneous delivery to support hemoglobin levels in specialized patient care protocols.